🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of this study is to evaluate the efficacy and safety of aspirin and...
Status
Not Yet Recruiting
Location
Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Start Date
2025-09-01
Trial ID
NCT06580223
Treatments Being Tested
This is a clinical study to evaluate the effectiveness and explore the poss...
Status
Completed
Location
Xikun Li
Start Date
2023-07-01
Trial ID
NCT07378228
The purpose of this study is to conduct a single-center, randomized, open-l...
Status
Unknown
Location
Peking Union Medical College Hospital
Start Date
2019-06-21
Trial ID
NCT04434365
Treatments Being Tested
The purpose of this study is to estimate the risk of bleeding with rivaroxa...
Status
Completed
Location
Multiple Locations
Start Date
2015-04-20
Trial ID
NCT02293395
Treatments Being Tested
This is a double-blind, randomized placebo-controlled trial which aims to e...
Status
Unknown
Location
Multiple Locations
Start Date
2021-03-01
Trial ID
NCT04661709
Intrastent restenosis is a common complication after intracranial and extra...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2023-10
Trial ID
NCT06112028
Treatments Being Tested
This is a prospective, randomized study to evaluate the effectiveness and s...
Status
Completed
Location
Renmin Hospital, Hubei University of Medicine
Start Date
2021-02-01
Trial ID
NCT07074834
Treatments Being Tested
The specific mechanistic benefit of rivaroxaban versus other FXa inhibitors...
Status
Completed
Location
Queen Mary Hospital, the University of Hong Kong
Start Date
2021-05-04
Trial ID
NCT06986369
Treatments Being Tested
This is a randomized, double-blind study. Human umbilical cord mesenchymal ...
Status
Suspended
Location
Inner Mongolia International Mongolian Hospital
Start Date
2026-12-31
Trial ID
NCT03176498